Abstract
14. Preclinical Pharmacology of DLX-001, a Novel Non-Hallucinogenic Neuroplastogen With the Potential for Treating Neuropsychiatric Diseases
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have